J B Chemicals and Pharmaceuticals Quarterly Results for Trading Insights
In Mar 2026, J B Chemicals and Pharmaceuticals (JBCHEPHARM) reported revenue ₹916 Cr and net profit ₹101 Cr — revenue -5.0% YoY. Browse JBCHEPHARM cash flow statement for revenue, profit, balance sheet and cash flow data.
JBCHEPHARM Quarterly Results — Revenue, Profit & EPS Highlights
J B Chemicals and Pharmaceuticals latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit JBCHEPHARM screener.
- Revenue of ₹916 Cr in Mar 2026 (-16.7% vs Sept 2025, -5.0% vs Mar 2025)
- Net Profit of ₹101 Cr in Mar 2026 (-51.4% vs Sept 2025, -30.8% vs Mar 2025)
- EBITDA of ₹186 Cr in Mar 2026 (-42.8% vs Sept 2025)
- Operating Margin of 19.0% in Mar 2026 (-10.0pp vs Sept 2025)
- Earnings Per Share of ₹6.35 in Mar 2026 (-52.2% vs Sept 2025)
J B Chemicals and Pharmaceuticals Quarterly Results — Revenue, EBITDA, Net Profit & EPS
JBCHEPHARM quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 916 | 1,100 | 964 | 1,109 | 1,083 | -16.7% | -5.0% |
| Net Profit (₹ Cr) | 101 | 208 | 146 | 202 | 198 | - | - |
| EBITDA (₹ Cr) | 186 | 325 | 241 | 315 | 314 | - | - |
| EPS (₹) | 6.35 | 13.29 | 9.36 | 12.99 | 12.63 | - | - |
| Operating Margin (%) | 19.0% | 29.0% | 24.0% | 28.0% | 28.0% | - | - |
JBCHEPHARM Share Price Trend — 1-Year Movement Across Quarterly Results
J B Chemicals and Pharmaceuticals 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore JBCHEPHARM share price history to track price trends across different timeframes.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
JBCHEPHARM vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
J B Chemicals and Pharmaceuticals latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹469,405.89 Cr | 1941.1 | 15,018 | 2,710 | +1.0% | +11.8% | 18.0% | 171.8 |
|
Divis Laboratories
Mar 2026 |
₹194,269.91 Cr | 7248.5 | 2,986 | 751 | +4.4% | +11.8% | 25.2% | 256.0 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹191,454.40 Cr | 4961.5 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 431.1 |
|
Zydus Life Science
Mar 2026 |
₹115,616.29 Cr | 1108.7 | 7,569 | 1,341 | +23.1% | +18.8% | 17.7% | 87.6 |
|
Cipla
Mar 2026 |
₹114,318.19 Cr | 1410.6 | 6,612 | 543 | -14.3% | -4.0% | 8.2% | 205.3 |
All amounts in ₹ Crores